Choice of Antidiabetic drugs in DM2 based on specific comorbidities
▪︎Metformin
▪︎SU .....sulfonylurea
▪︎SGLT-2-I ..... Sodium-glucose co-transporter-2 inhibitors
▪︎GLP-1 RA ..... (Glucagon-Like Peptide 1 Receptor Agonists)
▪︎DPP-4-I..... (Dipeptidyl Peptidase-4 Inhibitors)
▪︎TZD ...... (Thiazolidinediones)
▪︎insulin
#Endocrine
▪︎Metformin
▪︎SU .....sulfonylurea
▪︎SGLT-2-I ..... Sodium-glucose co-transporter-2 inhibitors
▪︎GLP-1 RA ..... (Glucagon-Like Peptide 1 Receptor Agonists)
▪︎DPP-4-I..... (Dipeptidyl Peptidase-4 Inhibitors)
▪︎TZD ...... (Thiazolidinediones)
▪︎insulin
#Endocrine
Approach Algorithm to Type 2 DM pharmacotherapy treatment 2023
When to consider start with combination pharmacotherapy ?!
When to consider early insulin initiation ?!
What r the main considerations in choicing anti diabetic drugs ?!
(Comorbidities ,
glucose lowering efficacy ,
weight loss efficacy ,
cost & access.
#Endocrine
When to consider start with combination pharmacotherapy ?!
When to consider early insulin initiation ?!
What r the main considerations in choicing anti diabetic drugs ?!
(Comorbidities ,
glucose lowering efficacy ,
weight loss efficacy ,
cost & access.
#Endocrine
Algorithm for Stroke heart syndrome
📍This is why every stroke patient should be monitored in ICU for at least 24 hrs , even he is completely stable
#Neurology
📍This is why every stroke patient should be monitored in ICU for at least 24 hrs , even he is completely stable
#Neurology